DONGWHA PHARM.CO.,LTD Logo

DONGWHA PHARM.CO.,LTD

Researches, develops, and sells a diverse range of healthcare products.

000020 | KO

Overview

Corporate Details

ISIN(s):
KR7000020008
LEI:
Country:
South Korea
Address:
서울특별시 중구 서소문로9길 20, 중구

Description

Dongwha Pharm is a pharmaceutical company engaged in the research, development, manufacturing, and sale of a diverse range of healthcare products. Its portfolio includes ethical (prescription) pharmaceuticals, over-the-counter (OTC) drugs, medical devices, quasi-drugs, health functional foods, cosmetics, and beverages. The company's research and development efforts focus on various therapeutic areas, including alimentary and cardiovascular systems. Dongwha Pharm actively pursues innovation through its drug pipeline, clinical trials, and strategic investments in emerging fields like digital therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 3.0 MB
2025-08-14 00:00
주식등의대량보유상황보고서(일반)
Korean 128.5 KB
2025-07-31 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.2 KB
2025-07-15 00:00
[기재정정]신규시설투자등
Korean 13.6 KB
2025-06-30 00:00
[기재정정]신규시설투자등
Korean 11.2 KB
2025-05-30 00:00
기업지배구조보고서공시
Korean 851.7 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 2.5 MB
2025-04-30 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 11.1 KB
2025-04-16 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-04-16 00:00
최대주주등소유주식변동신고서
Korean 52.2 KB
2025-03-26 00:00
정기주주총회결과
Korean 25.1 KB
2025-03-26 00:00
[기재정정]정기주주총회결과
Korean 31.0 KB
2025-03-26 00:00
대표이사(대표집행임원)변경(안내공시)
Korean 6.0 KB
2025-03-26 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.3 KB

Automate Your Workflow. Get a real-time feed of all DONGWHA PHARM.CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DONGWHA PHARM.CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DONGWHA PHARM.CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CORCEPT THERAPEUTICS INC Logo
Develops and commercializes cortisol-modulating medications for severe disorders.
United States of America
CORT
Corline Biomedical AB Logo
Develops heparin-based solutions for medical devices and regenerative medicine.
Sweden
CLBIO
CorMedix Inc. Logo
Biopharma firm developing therapeutics for infectious and inflammatory diseases.
United States of America
CRMD
Corvus Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing therapies for immune diseases and cancer.
United States of America
CRVS
Cosma Spolka Akcyjna Logo
Manufactures and distributes hemp and cannabis products for humans and animals.
Poland
COS
COSMO Pharmaceuticals N.V. Logo
A specialty pharmaceutical firm focused on gastroenterology, dermatology, and healthtech.
Netherlands
COPN
Cosmos Health Inc. Logo
Vertically integrated healthcare group in the nutraceutical and pharmaceutical sectors.
United States of America
COSM
Coya Therapeutics, Inc. Logo
Clinical-stage biotech developing therapies to enhance regulatory T cell function.
United States of America
COYA
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Logo
Clinical-stage biotech firm focused on regenerative medicine and immunotherapy.
United States of America
CELZ
CRESCENT BIOPHARMA, INC. Logo
Biopharmaceutical company researching and developing a pipeline of cancer therapies.
United States of America
CBIO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.